AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17557972 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention programs
Number of subjects: 7
Study 17557972 — intervention group
Group type: COMPARATOR
Intervention: Prevention programs
Number of subjects: 7
Study 14763634 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate program group (n = 23)
Number of subjects: 47
Study 14763634 — intervention group
Group type: COMPARATOR
Intervention: Delayed program control group (n = 24)
Number of subjects: 47
Study 11988188 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nitroglycerin 400 microg
Number of subjects: 55
Study 11988188 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold stress
Number of subjects: 55
Study 11988188 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 55
Study 9884140 — intervention group
Group type: EXPERIMENTAL
Intervention: Low alcohol beer (0.9%, v/v) consumed for 4 weeks
Number of subjects: 55
Study 9884140 — intervention group
Group type: COMPARATOR
Intervention: Full-strength beer (4.9%, v/v) consumed for 4 weeks
Number of subjects: 55
Study 9884140 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in CDT
Number of subjects: 55
Study 9884140 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in gamma-GT
Number of subjects: 55
Study 9884140 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% change in CDT
Number of subjects: 55
Study 9884140 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% change in gamma-GT
Number of subjects: 55
Study 7702049 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐HuEPO treatment
Number of subjects: 83
Study 7702049 — intervention group
Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 83
Study 1369848 — intervention group
Group type: EXPERIMENTAL
Intervention: Operated hips after Mc Kee‐Farrar total hip arthroplasty
Number of subjects: 84
Study 1369848 — intervention group
Group type: COMPARATOR
Intervention: Non-operated arthritic hips
Number of subjects: 84
Study 1369848 — intervention group
Group type: COMPARATOR
Intervention: Normal hips
Number of subjects: 84
Study 45602 — intervention group
Group type: EXPERIMENTAL
Intervention: Subunit vaccine at 600 CCA
Number of subjects: 202
Study 45602 — intervention group
Group type: EXPERIMENTAL
Intervention: Subunit vaccine at 200 CCA
Number of subjects: 202
Study 45602 — intervention group
Group type: COMPARATOR
Intervention: Whole-virus vaccine at 200 CCA
Number of subjects: 202
Study 30958054 — intervention group
Group type: EXPERIMENTAL
Intervention: RS-BFR (40% arterial occlusion pressure)
Number of subjects: 8
Study 30958054 — intervention group
Group type: EXPERIMENTAL
Intervention: RSH (systemic normobaric hypoxia, FiO2=14%)
Number of subjects: 8
Study 30958054 — intervention group
Group type: COMPARATOR
Intervention: RSN (normoxia)
Number of subjects: 8
Study 30958054 — intervention group
Group type: EXPERIMENTAL
Intervention: RS-BFR and RSH
Number of subjects: 8
Study 28196523 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education program
Number of subjects: 342
Study 26502971 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium treatment
Number of subjects: 616
Study 26502971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 616
Study 23635906 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent component neurofeedback (NFB)
Number of subjects: 20
Study 23635906 — intervention group
Group type: COMPARATOR
Intervention: Sham feedback (SFB)
Number of subjects: 20
Study 21768318 — intervention group
Group type: EXPERIMENTAL
Intervention: Frenotomy
Number of subjects: 58
Study 21768318 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 58
Study 19620428 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-head SPECT imaging
Number of subjects: 40
Study 19620428 — intervention group
Group type: COMPARATOR
Intervention: Planar imaging
Number of subjects: 40
Study 19620428 — intervention group
Group type: COMPARATOR
Intervention: Comparison of SPECT vs planar imaging
Number of subjects: 40
Study 18379519 — intervention group
Group type: EXPERIMENTAL
Intervention: Local injections of tolperisone (midocalm) combined with tractional therapy, 3-6 injections
Number of subjects: 49
Study 18379519 — intervention group
Group type: COMPARATOR
Intervention: Tractional therapy without midocalm (placebo)
Number of subjects: 49
Study 16116148 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-counseling program with up to six telephone calls from a trained childhood cancer survivor, tailored materials, and free nicotine replacement therapy
Number of subjects: 796
Study 16116148 — intervention group
Group type: COMPARATOR
Intervention: Self-help program
Number of subjects: 796
Study 11992864 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (Viagra) 100 mg
Number of subjects: 9
Study 11992864 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 9500298 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 7
Study 9500298 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 7
Study 9500298 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of salbutamol and salmeterol
Number of subjects: 7
Study 7587211 — intervention group
Group type: EXPERIMENTAL
Intervention: Post hoc covariate adjustment in RCTs
Number of subjects: 0
Study 2570012 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg nizatidine nocte
Number of subjects: 367
Study 2570012 — intervention group
Group type: COMPARATOR
Intervention: 300 mg ranitidine nocte
Number of subjects: 367
Study 4605245 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg iv
Number of subjects: 20
Study 4605245 — intervention group
Group type: COMPARATOR
Intervention: Dummy injection (Control)
Number of subjects: 20
Study 30646113 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based, culturally adapted, 6-session HIV/sexually transmitted disease risk-reduction intervention (Let Us Protect Our Future intervention)
Number of subjects: 1052
Study 30646113 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched, chronic disease prevention control intervention
Number of subjects: 1052
Study 28535825 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fruit and vegetable consumption
Number of subjects: 0
Study 26166657 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia combined with intercostal nerve block
Number of subjects: 80
Study 26166657 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia
Number of subjects: 80
Study 24139323 — intervention group
Group type: EXPERIMENTAL
Intervention: Strongest Families Smart Website intervention with weekly telephone coaching sessions
Number of subjects: 100
Study 24139323 — intervention group
Group type: COMPARATOR
Intervention: Education Control condition with access to a static website with parenting tips
Number of subjects: 100
Study 21913826 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib plus Melphalan and Prednisone (VMP)
Number of subjects: 682
Study 21913826 — intervention group
Group type: COMPARATOR
Intervention: Melphalan and Prednisone (MP) alone
Number of subjects: 682
Study 18326055 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward reaching tasks with low target height (109 cm) and self-selected speed
Number of subjects: 14
Study 18326055 — intervention group
Group type: EXPERIMENTAL
Intervention: Forward reaching tasks with high target height (153 cm) and as fast as possible speed
Number of subjects: 14
Study 18326055 — intervention group
Group type: EXPERIMENTAL
Intervention: Bland-Altman analysis
Number of subjects: 14
Study 18326055 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinematic outcome measures (e.g., peak hand velocity, endpoint error, reach extent, maximum shoulder flexion range of motion, minimum elbow extension range of motion)
Number of subjects: 14
Study 18326055 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak hand velocity, time to peak hand velocity, and movement time
Number of subjects: 14
Study 16895628 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole (group A)
Number of subjects: 20
Study 16895628 — intervention group
Group type: COMPARATOR
Intervention: No letrozole (group B)
Number of subjects: 20
Study 12706674 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 1) with Hib-CRM(197) (TETRAMUNE)
Number of subjects: 120
Study 12706674 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 2) with Hib-CRM(197) (TETRAMUNE)
Number of subjects: 120
Study 12706674 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 1) with Hib-OMPC (Group 2)
Number of subjects: 120
Study 12706674 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV-OMPC (lot 1)
Number of subjects: 120
Study 11142419 — intervention group
Group type: EXPERIMENTAL
Intervention: High waist-to-hip ratio (WHR > 0.92)
Number of subjects: 238
Study 11142419 — intervention group
Group type: EXPERIMENTAL
Intervention: High hip circumference (>97.4 cm)
Number of subjects: 238
Study 11142419 — intervention group
Group type: EXPERIMENTAL
Intervention: Height, usual adult weight, preadult and usual adult BMI
Number of subjects: 238
Study 8886999 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 (1 microgram/kg)
Number of subjects: 0
Study 8886999 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 (10 micrograms/kg)
Number of subjects: 0
Study 8886999 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-10 (25 micrograms/kg)
Number of subjects: 0
Study 8886999 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2058593 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy-protein beverage
Number of subjects: 0
Study 2058593 — intervention group
Group type: COMPARATOR
Intervention: Cow-milk protein
Number of subjects: 0
Study 6355314 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg, 10-day course, four times daily)
Number of subjects: 99
Study 6355314 — intervention group
Group type: COMPARATOR
Intervention: Rosaramicin (250 mg, 10-day course, four times daily)
Number of subjects: 99
Study 30395052 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg)
Number of subjects: 48
Study 30395052 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 30270178 — intervention group
Group type: COMPARATOR
Intervention: High hsCRP (groups C and D)
Number of subjects: 1734
Study 30270178 — intervention group
Group type: EXPERIMENTAL
Intervention: Low hsCRP (group A)
Number of subjects: 1734
Study 30270178 — intervention group
Group type: COMPARATOR
Intervention: Low hsCRP with renal impairment (group B)
Number of subjects: 1734
Study 27079848 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose IgG (M = 794.93; SD = 90.48)
Number of subjects: 12
Study 27079848 — intervention group
Group type: COMPARATOR
Intervention: Low dose IgG (M = 283.89; SD = 71.10)
Number of subjects: 12
Study 27079848 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-case experimental designs (MD = 495.00; SE = 54.41)
Number of subjects: 12
Study 24791643 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 164
Study 24791643 — intervention group
Group type: COMPARATOR
Intervention: Imagery Relief Therapy (IRT)
Number of subjects: 164
Study 22968245 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support following new clinical guidelines from admission to five days postoperatively
Number of subjects: 88
Study 22968245 — intervention group
Group type: COMPARATOR
Intervention: Regular nutritional support pre- and postoperatively (Control)
Number of subjects: 88
Study 22968245 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional support following new clinical guidelines
Number of subjects: 88
Study 22968245 — intervention group
Group type: COMPARATOR
Intervention: Nutritional support (both groups)
Number of subjects: 88
Study 19560905 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (0.5 mg/kg)
Number of subjects: 9
Study 19560905 — intervention group
Group type: COMPARATOR
Intervention: Procaine (0.5 mg/kg and 1.0 mg/kg)
Number of subjects: 9
Study 19560905 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 9
Study 18044436 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccination (three doses at 3-week intervals)
Number of subjects: 288
Study 18044436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 288
Study 16108507 — intervention group
Group type: EXPERIMENTAL
Intervention: Phloroglucinol
Number of subjects: 100
Study 16108507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 12164741 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional diamond fraise dermabrasion
Number of subjects: 21
Study 12164741 — intervention group
Group type: COMPARATOR
Intervention: Manual dermabrasion with medium-grade drywall sanding screen
Number of subjects: 21
Study 9933773 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised Nidek EAS‐1000 densitometric analysis of the lens
Number of subjects: 1204
Study 9933773 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment of the nucleus
Number of subjects: 1204
Study 7473002 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol-containing mouthrinses
Number of subjects: 0
Study 7473002 — intervention group
Group type: COMPARATOR
Intervention: Ethanol/water controls
Number of subjects: 0
Study 7473002 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear Choice mouthrinse (marketed product)
Number of subjects: 0
Study 2097484 — intervention group
Group type: COMPARATOR
Intervention: 2 mg epidural morphine in 2 ml saline
Number of subjects: 90
Study 2097484 — intervention group
Group type: COMPARATOR
Intervention: 2 mg epidural morphine in 10 ml saline
Number of subjects: 90
Study 2097484 — intervention group
Group type: COMPARATOR
Intervention: 2 mg epidural morphine in 20 ml saline
Number of subjects: 90
Study 7027745 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. infusion of verapamil during standardized oral glucose load
Number of subjects: 21
Study 7027745 — intervention group
Group type: EXPERIMENTAL
Intervention: oral verapamil treatment after one week during standardized oral glucose load
Number of subjects: 21
Study 7027745 — intervention group
Group type: COMPARATOR
Intervention: oral placebo during standardized oral glucose load
Number of subjects: 21
Study 31689758 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive education and care (CEC) program
Number of subjects: 136
Study 31689758 — intervention group
Group type: COMPARATOR
Intervention: Basic health education and rehabilitation
Number of subjects: 136
Study 29750673 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy and temozolomide
Number of subjects: 111
Study 26796950 — intervention group
Group type: EXPERIMENTAL
Intervention: Framing the decision as the patient's vs the surrogate's (25% vs 36%)
Number of subjects: 220
Study 26796950 — intervention group
Group type: EXPERIMENTAL
Intervention: Describing the alternative to CPR as 'allow natural death' instead of 'do not resuscitate' (25% vs 37%)
Number of subjects: 220
Study 26796950 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall optimism bias (30% of 220)
Number of subjects: 220
Study 26796950 — intervention group
Group type: EXPERIMENTAL
Intervention: Accurate recollection of physician's estimate (32% of 173)
Number of subjects: 220
Study 26796950 — intervention group
Group type: COMPARATOR
Intervention: Emotion priming
Number of subjects: 220
Study 26796950 — intervention group
Group type: COMPARATOR
Intervention: Physician attention to emotion
Number of subjects: 220
Study 26796950 — intervention group
Group type: COMPARATOR
Intervention: Framing of CPR as the social norm
Number of subjects: 220
Study 25280810 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (What Were We Thinking) for the prevention of postnatal mental health problems
Number of subjects: 0
Study 25280810 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 22357413 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg for 12 weeks
Number of subjects: 0
Study 22357413 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 10 mg for 12 weeks
Number of subjects: 0
Study 22357413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19966850 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigenemia group
Number of subjects: 88
Study 19966850 — intervention group
Group type: COMPARATOR
Intervention: PCR group
Number of subjects: 88
Study 19966850 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 17581448 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release methylphenidate (MPH-IR) at doses of 0.1, 0.3, and 0.5 mg/kg twice daily for 2 weeks.
Number of subjects: 71
Study 17581448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 15248531 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning approach using adapted tight frame decompositions and support vector machines with radial kernels
Number of subjects: 0
Study 15248531 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning approach
Number of subjects: 0
Study 11756063 — intervention group
Group type: COMPARATOR
Intervention: Control-1 (sterol-free)
Number of subjects: 46
Study 11756063 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterol ester-1 (2.3 g plant sterol esters)
Number of subjects: 46
Study 11756063 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanol ester-1 (2.5 g plant stanol esters)
Number of subjects: 46
Study 9690243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 5 mg
Number of subjects: 123
Study 9690243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 25 mg
Number of subjects: 123
Study 9690243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 50 mg
Number of subjects: 123
Study 9690243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 100 mg
Number of subjects: 123
Study 9690243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromfenac 200 mg
Number of subjects: 123
Study 9690243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 8106772 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine, 25 mg thrice weekly
Number of subjects: 335
Study 8106772 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 335
Study 8106772 — intervention group
Group type: COMPARATOR
Intervention: Aerosolized pentamidine
Number of subjects: 335
Study 2669218 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone only series (60 mg daily for one month, then reduced to 20 mg on alternate days)
Number of subjects: 43
Study 2669218 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide-prednisolone series (100-120 mg cyclophosphamide daily plus 20 mg prednisolone on alternate days)
Number of subjects: 43
Study 2669218 — intervention group
Group type: EXPERIMENTAL
Intervention: Death or failure of first treatment regimen
Number of subjects: 43
Study 2669218 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lung capacity (TLC) on admission
Number of subjects: 43
Study 58317 — intervention group
Group type: EXPERIMENTAL
Intervention: Armovical spatula
Number of subjects: 0
Study 58317 — intervention group
Group type: COMPARATOR
Intervention: Ayre's spatula
Number of subjects: 0
Study 58317 — intervention group
Group type: EXPERIMENTAL
Intervention: Sampling cervix twice
Number of subjects: 0
Study 31520538 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 90
Study 31520538 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite splint therapy
Number of subjects: 90
Study 31520538 — intervention group
Group type: COMPARATOR
Intervention: Home exercise
Number of subjects: 90
Study 30786914 — intervention group
Group type: EXPERIMENTAL
Intervention: Accuhaler
Number of subjects: 0
Study 30786914 — intervention group
Group type: COMPARATOR
Intervention: MDI/s
Number of subjects: 0
Study 28074796 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity laser therapy (660 NM, spatial average energy fluency of 1.06 J/cm2)
Number of subjects: 90
Study 28074796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 28074796 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 25488186 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual transcranial direct current stimulation applied bilaterally over the primary motor cortex during motor skill learning with the paretic upper limb
Number of subjects: 19
Study 25488186 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual transcranial direct current stimulation
Number of subjects: 19
Study 25488186 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study 24622367 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone messaging intervention
Number of subjects: 537
Study 24622367 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 537
Study 21159483 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention pain control self-efficacy
Number of subjects: 244
Study 21159483 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention communication self-efficacy
Number of subjects: 244
Study 19492956 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day application of topical 0.5% moxifloxacin, 4 times a day for 1 day, n = 63
Number of subjects: 144
Study 16988065 — intervention group
Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Hispanic, Black, Asian, Native American, Other)
Number of subjects: 6677
Study 16988065 — intervention group
Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Black)
Number of subjects: 6677
Study 16988065 — intervention group
Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Asian)
Number of subjects: 6677
Study 16988065 — intervention group
Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Native American)
Number of subjects: 6677
Study 16988065 — intervention group
Group type: COMPARATOR
Intervention: Racial/Ethnic minority groups (Other)
Number of subjects: 6677
Study 15050762 — intervention group
Group type: EXPERIMENTAL
Intervention: ETT palpation and adjustment (Treatment)
Number of subjects: 55
Study 15050762 — intervention group
Group type: COMPARATOR
Intervention: ETT palpation and non-adjustment (Controls)
Number of subjects: 55
Study 15050762 — intervention group
Group type: EXPERIMENTAL
Intervention: ETT palpation
Number of subjects: 55
Study 17767063 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet control group (low-salt, low-cholesterol, low-calorie, high-cellulose diet)
Number of subjects: 60